Biomedical Catalyst 2022 Round 1: Industry-led R&D
Innovate UK has opened its ‘Biomedical Catalyst 2022 Round 1: Industry-led Research and Development’ fund for UK-registered micro, small or medium-sized enterprises wishing to develop innovative solutions to healthcare challenges.
Applications can be made from 28 March 2022 until 25 May 2022.
Innovate UK, part of UK Research and Innovation will invest up to £15 million in projects to support UK registered businesses to develop innovative health or healthcare-focussed products, technologies and processes.
Your project can focus on:
- disease prevention and proactive management of health and chronic conditions
- earlier and better detection and diagnosis of disease, leading to better patient outcomes
- tailored treatments that either change the underlying disease or offer potential cures
- the development of digital health technologies
This list is not intended to be exhaustive.
The Industry-led research and development (R&D) stream of the Biomedical Catalyst programme supports pre-market R&D projects. Applicants must be able to demonstrate existing evidence of commercial and technical feasibility.
In applying to this competition, you are entering into a competitive process. This competition closes at 11am UK time on the 25th of May 2022.